Medical Condition News

RSS

Research team receives NCI grant to develop precision therapies that kill cancer cells

A research team headed by Fred Hutchinson Cancer Research Center scientists Christopher Kemp, Ph.D., and Carla Grandori, M.D., Ph.D., has received a $4 million grant from the National Cancer Institute to develop precision therapies that selectively kill cancer cells while sparing normal, healthy tissue.

24 Jul 2013

Researchers develop reliable way to use finger-stick blood sample to detect fibromyalgia syndrome

Researchers have developed a reliable way to use a finger-stick blood sample to detect fibromyalgia syndrome, a complicated pain disorder that often is difficult to diagnose.

24 Jul 2013

Scientists reveal new images of how white blood immune cells attack tumours, viral infections

Scientists from The University of Manchester have revealed new images which provide the clearest picture yet of how white blood immune cells attack viral infections and tumours.

From The University of Manchester 24 Jul 2013

Genentech announces that Phase III CLL11 study meets primary endpoint

Genentech, a member of the Roche Group, today announced positive results from the Phase III CLL11 study. At a pre-planned interim analysis, an independent data monitoring committee determined that the study met its primary endpoint showing that GA101 plus chlorambucil helped people live significantly longer without their disease worsening (progression-free survival; PFS) compared to Rituxan (rituximab) plus chlorambucil.

24 Jul 2013

FDA takes action to remove illegal diabetes products from market

The U.S. Food and Drug Administration is taking action to remove from the market illegal products, including some labeled as dietary supplements, that claim to mitigate, treat, cure or prevent diabetes and related complications.

24 Jul 2013

Astrocytes can protect brain tissue and reduce disability due to stroke

One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.

24 Jul 2013

TYRX's AIGISRx Antibacterial Envelope gets FDA clearance

TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance to market the AIGISRx Antibacterial Envelope for use with vagus nerve stimulators, which are currently used to treat seizure disorders and depression.

24 Jul 2013

Digital versions of standard molecular biology tool to detect common tumor-associated mutation in CSF

Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.

24 Jul 2013

New approaches provide lifetime support for individuals with ASD

More than 300 parents, healthcare providers and educators from across the U.S. and around the world, will come together July 26 through July 27, 2013 at the second annual national conference for families and professionals, "Treating the Whole Person with Autism: Care Across the Lifespan." The conference — sponsored by Autism Speaks, the world's leading autism and advocacy organization, with our educational partners at Nationwide Children's Hospital, Ohio State University Wexner Medical Center, the U.S.

24 Jul 2013

Study: Kidney stones linked with increased risk of CHD among women, but not men

An analysis of data from three studies that involved a total of more than 240,000 participants found that a self-reported history of kidney stones was associated with a statistically significant increased risk of coronary heart disease among women but no significant association was evident for men, according to a study in the July 24/31 issue of JAMA.

24 Jul 2013

Research: No association between pre-natal mercury exposure and autism-like behaviors

The potential impact of exposure to low levels of mercury on the developing brain - specifically by women consuming fish during pregnancy - has long been the source of concern and some have argued that the chemical may be responsible for behavioral disorders such as autism.

24 Jul 2013

Prana Biotechnology completes PBT2 phase 2 trial in patients with Huntington's disease

Prana Biotechnology today announced the successful completion of Reach2HD, a phase 2 clinical trial in patients with early to mid-stage Huntington disease. The Company expects to announce the results arising from the trial in October.

23 Jul 2013

MUCMD Symposium to be held at The Saban Research Institute of Children's Hospital Los Angeles

On August 16 and 17, the 3rd annual Meaningful Use of Complex Medical Data Symposium is returning to The Saban Research Institute of Children's Hospital Los Angeles.

23 Jul 2013

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Presently, it is a diagnosis of exclusion. Patients end up spending, according to what’s been published in the medical literature, as many as 3 - 5 years going from doctor to doctor seeking a diagnosis because they tend to have nonspecific symptoms of a subjective nature.

23 Jul 2013

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

Array BioPharma Inc. today announced positive results from a placebo-controlled, randomized, double‑blind Phase 2 trial in mild to moderate persistent allergic asthma for ARRY-502, an oral CRTh2 antagonist.

23 Jul 2013

Discovery may help explain how anti-inflammatory steroid drugs work

A gene long presumed dead comes to life under the full moon of inflammation, Stanford University School of Medicine scientists have found.

23 Jul 2013

Novaliq receives CE mark approval for EyeSol technology

Novaliq GmbH, a drug delivery company with a focus on the topical application of ophthalmic technologies for poorly soluble drugs, today announced the successful CE mark approval for the first topical eye lubricant based on Novaliq's proprietary technology EyeSol.

23 Jul 2013

Medical Condition News

Research team receives NCI grant to develop precision therapies that kill cancer cells

Researchers develop reliable way to use finger-stick blood sample to detect fibromyalgia syndrome

Scientists reveal new images of how white blood immune cells attack tumours, viral infections

Genentech announces that Phase III CLL11 study meets primary endpoint

FDA takes action to remove illegal diabetes products from market

Astrocytes can protect brain tissue and reduce disability due to stroke

TYRX's AIGISRx Antibacterial Envelope gets FDA clearance

Digital versions of standard molecular biology tool to detect common tumor-associated mutation in CSF

New approaches provide lifetime support for individuals with ASD

Study: Kidney stones linked with increased risk of CHD among women, but not men

Research: No association between pre-natal mercury exposure and autism-like behaviors

Prana Biotechnology completes PBT2 phase 2 trial in patients with Huntington's disease

MUCMD Symposium to be held at The Saban Research Institute of Children's Hospital Los Angeles

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

Discovery may help explain how anti-inflammatory steroid drugs work

Novaliq receives CE mark approval for EyeSol technology

Incentives for Ontario surgeons drive greater use of laparoscopic colon cancer surgery

Understanding cancer at source could improve disease prevention

Potential breakthrough to help prevent diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News